cerrar

Turkey

Turkey / Roche Digital Platform; Big Pharma Earthquake Aid; IHH Healthcare/Kent Health Deal

A roundup of the latest pharma and healthcare news from Turkey including Roche Turkey's digital platform for HCPs and patients, big pharma's aid to earthquake victims, the Scientific and Technological Research Council's new manufacturing facility and IHH Healthcare's acquisition of…

MEA / 5 Regional Pharma Trends to Watch

The Middle East and Africa (MEA), the fifth-largest regional pharma market in the world, is rapidly becoming a pharmaceutical powerhouse with both global and local firms taking advantage of the…

Turkey / Gilead Pursuing Localization

After its best financial year to date – posting revenues of USD 27.3 billion in 2021 – Gilead has said yes to localization in Turkey. The California-based company, known for…

Turkey / Turkey’s Pharma Market and Key Players

Turkey’s pharma market, the 18th largest in the world and valued at USD 7 Billion in 2020, has seen steady growth over the past few years due to favorable healthcare…

In Conversation

Turkey Roundup: Roche Digital Platform; Big Pharma Earthquake Aid; IHH Healthcare/Kent Health Deal

A roundup of the latest pharma and healthcare news from Turkey including Roche Turkey’s digital platform for HCPs and patients, big pharma’s aid to earthquake victims, the Scientific and Technological Research Council’s new manufacturing facility and IHH Healthcare’s acquisition of Kent Health Group.   Pharma 2023: Roche Turkey’s Digital Platform for HCPs and Patients (PharmExec) Gizem Özbayraç, head of business,…

Turkey Roundup: Roche Digital Platform; Big Pharma…

Turkey Roundup: Roche Digital Platform; Big Pharma…

Turkey / Roche Digital Platform; Big Pharma Earthquake Aid; IHH Healthcare/Kent Health Deal

A roundup of the latest pharma and healthcare news from Turkey including Roche Turkey’s digital platform for HCPs and patients, big pharma’s aid to earthquake victims, the Scientific and Technological…

Related Report

Turkey / Can It Become a True Clinical Trials Hub?

Becoming the clinical trials country leader in the region has been set as a primary goal for Turkey’s pharma industry to achieve global competitiveness. The government’s strategy is to increase…

Turkey / Global Competitiveness: Where & Why Locals are Exporting

When the Turkish Ministry of Health implemented its strategy to transition from import pharmaceuticals to manufacturing them at home in 2016, the local industry leveraged the situation to invest in…

Turkey / Solidarity: How COVID-19 Brought the Turkish R&D Ecosystem Together

As an upper-middle-income country with an emerging economy, Turkey could not invest billions in COVID-19 vaccine R&D, but a strong research ecosystem and willing industry allowed it to kickstart multiple…

Turkey / Minister of Health's Top 4 Priorities

Overseeing healthcare for a population of over 80 million, Turkey’s Ministry of Health was put under the spotlight during the COVID-19 pandemic. Here, we highlight four of the hot-button items…

Turkey / Shifting Priorities: Clinical Trials, Biologics, R&D Investment

There are perhaps no two words that better summarize the last few years in Turkish pharma than localization and pricing. But after years of investment and struggles, the country’s priorities…

We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here